Goeman, C. J. (2017). The Price Isn’t Right: Shareholder Proposals as Opportunities for Institutional Investors to Restore Firm Value and Reduce Pharmaceutical Prices. Columbia Business Law Review, 2017(2), 748–806. https://doi.org/10.7916/cblr.v2017i2.1723